Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

<h4>SUMMARY</h4> <h4>Background</h4> Aspirin has been proposed as a treatment for COVID-19 on the basis of its antithrombotic properties. <h4>Methods</h4> In this randomised, controlled, open-label platform trial, se...

Full description

Bibliographic Details
Main Authors:	RECOVERY Collaborative Group, Horby, P, Pessoa-Amorim, G, Staplin, N, Emberson, J, Campbell, M, Spata, E, Peto, L, Brunskill, N, Tiberi, S, Chew, V, Brown, T, Tahir, H, Ebert, B, Chadwick, D, Whitehouse, T, Sarkar, R, Graham, C, Baillie, K, Basnyat, B, Buch, M, Chappell, L, Day, J, Faust, S, Hamers, R, Jaki, T, Juszczak, E, Jeffery, K, Lim, WS, Montgomery, A, Mumford, A, Rowan, K, Thwaites, G, Mafham, M, Haynes, R, Landray, M
Format:	Journal article
Language:	English
Published:	medRxiv 2021

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Similar Items